Work

Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists

Year: 2022

Type: review

Abstract: The risk of cardiovascular diseases is closely related to diabetes. Macrovascular disease is the main cause of death and disability in patients with type 2 diabetes. In recent years, the glucagon-like peptide-1 receptor agonist (GLP-1RA), a new type of hypoglycemic drug, has been shown to regulate blood sugar levels, improve myocardial ischemia, regulate lipid metabolism, improve endothelial function, and exert a protective role in the cardiovascular system. This study reviewed the protective effects of GLP-1RA on the cardiovascular system.

Source: Journal of Diabetes Research

DOI: 10.1155/2022/4554996

Authors: Rui Song, Hang Qian, Yunlian Wang, Qingmei Li, Dongfeng Li, Jishun Chen, Jingning Yang, Jixin Zhong, Handong Yang, Xinwen Min, Hao Xu, Yong Yang, Jun Chen

Institutions: Hubei University of Medicine, China National Pharmaceutical Group Corporation (China), Dongfeng General Hospital, Tongji Hospital, Huazhong University of Science and Technology

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,760

Funders: National Natural Science Foundation of China, Hubei University of Medicine, Hubei University, Hubei Key Laboratory of Wudang Local Chinese Medicine Research

Awards: G1996424147, G2333512115, G366493921, G3689164436, G3721644317, G3729621600, G3804576819, G4444857929, G4706249427, G5004748736, G5022285775, G5323397502, G54551188, G5491917416, G5690774525, G6375314190, G7924727497, G8168031337, G8670097968

OpenAlex ID: W4225894630

FWCI: 0.249

Cites: 76

Cited by: 8

Related to: 10